Table V.
Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|
Variables | Patients, n | HR (95% CI) | P-value | HR (95% CI) | P-value |
Age (<60/≥60 years) | 131/351 | 1.04 (0.70–1.56) | 0.83 | 1.17 (0.77–1.77) | 0.47 |
Gender (male/female) | 260/222 | 0.88 (0.61–1.27) | 0.49 | 0.82 (0.57–1.20) | 0.31 |
Pathological stage (I–II/III–IV) | 377/105 | 2.82 (1.94–4.09) | 0.00 | 1.68 (1.02–2.77) | 0.04 |
T stage (T1-T2/T3-T4) | 417/65 | 2.49 (1.55–4.00) | 0.00 | 1.46 (0.85–2.50) | 0.17 |
N stage (N0/NX) | 312/170 | 2.78 (1.92–4.01) | 0.00 | 1.80 (1.15–2.83) | 0.01 |
M stage (M0/MX) | 318/164 | 0.87 (0.58–1.30) | 0.49 | 0.90 (0.59–1.36) | 0.61 |
Risk score (low/high) | 238/244 | 0.39 (0.26–0.58) | 0.00 | 0.51 (0.34–0.76) | 0.00 |
HR, hazard ratio; CI, confidence interval.